Alembic Pharmaceuticals completes USFDA inspection for API-III Facility at Karakhadi

22 Mar 2025 Evaluate

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Administration (USFDA) inspection for its API-III Facility located at Karakhadi. This was a scheduled GMP inspection and was successfully completed without any Form 483 observation. The inspection was conducted from March 17, 2025 to March 21, 2025. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Alembic Pharma Share Price

825.15 -13.35 (-1.59%)
06-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.15
Dr. Reddys Lab 1255.95
Cipla 1530.35
Zydus Lifesciences 931.25
Lupin 2151.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×